BCR and chronic myelogenous leukemia, BCR-ABL1 positive: These results indicated that BCR-ABL tyrosine kinase signaling in CML cells was effectively inhibited by the targeted disruption ofBCR-ABL by Cas9-GFP/dual-BA-sgRNA.